Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04485208
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2022-09-28
First Post:
2020-07-21
Brief Title:
Focused Ultrasound for the Treatment of Neuropathic Pain
Sponsor:
Neurological Associates of West Los Angeles
Organization:
Neurological Associates of West Los Angeles
Study Overview
Official Title:
Open Label Study for the Use of Focused Transcranial Ultrasound for Treatment of Neuropathic Pain
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A possible treatment approach for neuropathic pain would employ a process designed to promote healthier function of the ventral posteromedial VPM and ventral posterolateral VPL thalamic nuclei This study is designed to employ focused ultrasound technology to target the VPM and VPL thalamus among participants with ongoing neuropathic pain syndromes to evaluate for tolerability and early efficacy
Detailed Description:
The present open-label study is being undertaken to evaluate focused transcranial ultrasound therapy as an intervention for patients with neuropathic pain The subjects in this research study will be recruited through medical practice Participants who are enrolled will undergo 8 consecutive weekly ultrasound sessions Targeting for treatment will be based on patient MRI scans using stereotaxic techniques
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None